| Article Access Statistics | | | Viewed | 5556 | | | Printed | 202 | | | Emailed | 0 | | | PDF Downloaded | 55 | | | Comments | [Add] | | | Cited by others | 6 | | |
|
Click on image for details.
|
|
 |
| LETTER TO EDITOR |
|
|
|
| Year : 2011 | Volume
: 59
| Issue : 4 | Page : 628-630 |
Meningeal tuberculoma mimicking chloroma in a patient with chronic myeloid leukemia on imatinib
Pravin Salunke1, Kirti Gupta2, Navneet Singla1, Harnarayan Singh1, Paramjeet Singh3, Kanchan K Mukherjee1
1 Department of Neurosurgery, PGIMER, Chandigarh, India
2 Department of Histopathology, PGIMER, Chandigarh, India
3 Department of Radiodiagnosis Histopathology, PGIMER, Chandigarh, India
| Date of Submission | 27-Apr-2011 |
| Date of Decision | 30-Apr-2011 |
| Date of Acceptance | 19-May-2011 |
| Date of Web Publication | 30-Aug-2011 |
Correspondence Address:
Kanchan K Mukherjee
Department of Neurosurgery, PGIMER, Chandigarh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0028-3886.84354
How to cite this article:
Salunke P, Gupta K, Singla N, Singh H, Singh P, Mukherjee KK. Meningeal tuberculoma mimicking chloroma in a patient with chronic myeloid leukemia on imatinib. Neurol India 2011;59:628-30 |
How to cite this URL:
Salunke P, Gupta K, Singla N, Singh H, Singh P, Mukherjee KK. Meningeal tuberculoma mimicking chloroma in a patient with chronic myeloid leukemia on imatinib. Neurol India [serial online] 2011 [cited 2023 Nov 29];59:628-30. Available from: https://www.neurologyindia.com/text.asp?2011/59/4/628/84354 |
Sir,
Central nervous system (CNS) lesions complicating chronic myeloid leukemia (CML) are rare and a meningeal enhancing lesion in a patient with CML is usually suspected to be a chloroma. [1] We report meningeal tuberculoma mimicking chloroma in a patient with CML on imatinib.
A 43-years-female, a known case of CML on imatinib 400 mg per day since 6 years, presented with headache and vomiting without fever and other constitutional symptoms of one week duration. Examination revealed bilateral papilledema and no signs of meningitis. Abdominal ultrasound revealed no hepato-splenomegaly and the chest X-ray was normal. Investigations: Hemoglobin 8.8 g/dl, total leucocyte count (TLC) 11,700/cu mm, and platelet count 5,68,000/cu mm. Patient was started on dexamethasone and the dose of imatinib was stepped up from 400 mg to 600 mg per day. Contrast magnetic resonance imaging (MRI) brain revealed a left temporal meningeal lesion with intense meningeal enhancement. There was an evidence of uncal herniation. The adjacent bone diploe appeared normal [Figure 1]a-d. In view of features of raised intracranial pressure and temporal mass with uncal herniation, decompression with biopsy was planned. The lesion was adherent to the adjacent dura matter, firm to hard in consistency and had both solid and soft areas. Cisternal cerebrospinal fluid (CSF) and tumor fluid analysis were noncontributory. Post-op recovery was complicated by high grade fever of unknown origin and did not respond to broad spectrum antibiotics. Post-op TLC was 19,300/cu mm. Biopsy confirmed meningeal-based tubercoma. [Figure 2]a-d. She was started with anti-tubercular therapy (ATT). Response to ATT was promising initially and she became afebrile by day-6. In addition, she was on imatinib and steroids. However, a month later, she presented with altered sensorium. Contrast MRI showed basal exudates and infarcts secondary to vasculitis [Figure 1]d and e. Lumbar puncture done at this stage revealed mild pleocytosis and was negative for Acid Fast Bacilli and culture. She continued to be on altered sensorium, intermittently opening her eyes and moving her limbs, despite being on 8 weeks of steroids and ATT. | Figure 1: (a) T1 weighted MRI showing lesion in the right temporal lobe with cystic and solid component. The solid component is isointense. (b) Contrast MRI reveals the solid component is meningeal and enhances on contrast. The diploe in adjacent bone is normal. There is an evidence of early uncal herniation (c) T2 weighted MRI showing well defined cyst. (d) Flair coronal MRI showing the extent of edema. (e) Post-op contrast MRI one month later showing appearance of basal exudates. (f) Flair images a month later showing bilateral developing infarcts due to vasculitis
Click here to view |
 | Figure 2: (a) Expanded subarachnoid space filled with numerous well formed epithelioid cell granuloma and langhans giant cells along with fibrosis (H and E, ×100) (b) High magnification showing the epithelioid cell granuloma with giant cells (H and E, ×200). (c) Extension of granuloma and inflammation along the Virchow-Robin space (H and E, ×200). (d) Ziehl-Neelsen (ZN) stain demonstrated the presence of occasional acid-fast bacilli, (arrow) (ZN ×1000)
Click here to view |
CNS involvement in leukemias is rare and is usually seen in acute myeloid leukemia (AML). Meningeal or parenchymal lesion in these patients is likely to be chloroma/granulocytic sarcoma. [2] The leukemic cells possibly migrate from bone marrow via haversian canals to the periosteum and then infiltrate the dura matter and brain parenchyma by subarachnoid perivenous adventitial tissue or by direct hematogenous spread or hematopoetic cell differentiation in embryonic cells in CNS. [2] In the absence of acute leukemia, chloroma suggests imminent conversion to AML or blast crisis and is an ominous sign. [2] Typically on MRI, the lesion appears isointense or slightly hypointense in T 1 - and T 2 -weighted images with homogeneous contrast enhancement. [3] Associated bone marrow (diploe) involvement helps differentiating these tumors from other intracranial lesions. [3] Meningeal chloroma can mimic meningioma, lymphoma, metastasis, and even herpes simplex encephalitis. [2],[4]
Imatinib is the first-line treatment for CML. Isolated CNS relapse in cases of CML on imatinib has been reported. [1] Low levels of imatinib in the CSF due to its active out transport by the membrane-bound transport protein (P-glycoprotein) makes the CNS a sanctuary site for leukemic cells. [1] Tyrosine kinase plays an important role in T-cell receptor signal transduction and imatinib has been shown to affect T-cell receptor signal transduction, thereby, affecting the cellular immunity; leaving the host susceptible to reactivation of tuberculosis. [5] This is true for extra CNS tuberculosis and its role in CNS tuberculosis is unclear. Meningeal based tuberculoma is a rare manifestation of CNS tuberculosis. In this patient, repeat CSF showed pleocytosis. Whether it is related to tuberculous pathology or CNS leukemia is uncertain. [6] Generally, the response to ATT in CNS tuberculosis is favorable unless the disease is severe at the start of the treatment. [6] Our patient illustrates the fact that one should have a high index of suspicion of CNS tuberculosis in patients with CML on imatinib with meningeal based lesion, more in countries endemic to tuberculosis. Biopsy of the lesion helps differentiate tuberculosis from chloroma.
| » References | |  |
| 1. | Johnson NA, Fetni R, Caplan SN. Isolated central nervous system relapse in patients with chronic myeloid leukemia on imatinib mesylate. Leuk Lymphoma 2005;46:629-30. 
[PUBMED] [FULLTEXT] |
| 2. | Shah RS, Shin RK, Castellani RJ. Granulocytic sarcoma mimicking HSV encephalitis. Neurologist 2010;16:319-21.
[PUBMED] [FULLTEXT] |
| 3. | Hakyemez B, Yildirim N, Taskapilioglu O, Erdogan C, Aker S, Yilmazlar S, et al. Intracranial myeloid sarcoma: Conventional and advanced MRI findings. Br J Radiol 2007;80:e109-12.
[PUBMED] [FULLTEXT] |
| 4. | Ahn JY, Kwon SO, Shin MS, Kang SH, Kim YR. Meningeal chloroma (granulocytic sarcoma) in acute lymphoblastic leukemia mimicking a falx meningioma. J Neurooncol 2002;60:31-5.
[PUBMED] [FULLTEXT] |
| 5. | Daniels JM, Vonk-Noordegraaf A, Janssen JJ, Postmus PE, van Altena R. Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia. Eur Respir J 2009;33:670-2.
[PUBMED] [FULLTEXT] |
| 6. | Weiser MA, O'Brien S, Escalante C, Manzullo E. Tuberculosis meningitis in a patient with acute myelogenous leukemia. Leuk Lymphoma 1999;33:187-92.
[PUBMED] [FULLTEXT] |
[Figure 1], [Figure 2]
| This article has been cited by | | 1 |
Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia |
|
| Makoto Moriguchi, Hideo Koh, Tetsuya Hayashi, Hiroshi Okamura, Satoru Nanno, Yasuhiro Nakashima, Takahiko Nakane, Waki Imoto, Koichi Yamada, Hiroshi Kakeya, Masayuki Hino, Hirohisa Nakamae | | Journal of Infection and Chemotherapy. 2020; 26(10): 1054 | | [Pubmed] | [DOI] | | | 2 |
Renal tuberculosis in an imatinib-treated chronic myeloid leukemia |
|
| Abhilash Chandra, Namrata Rao, Kiran Preet Malhotra | | Brazilian Journal of Nephrology. 2020; 42(3): 366 | | [Pubmed] | [DOI] | | | 3 |
Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report |
|
| Johannes Kerschbaumer,Christian F. Freyschlag,Günter Stockhammer,Susanne Taucher,Hans Maier,Claudius Thomé,Marcel Seiz-Rosenhagen | | Journal of Neurosurgery. 2016; 124(1): 137 | | [Pubmed] | [DOI] | | | 4 |
Risk and impact of tuberculosis in patients with chronic myeloid leukemia: A nationwide population-based study in Taiwan |
|
| Chia-Jen Liu,Ying-Chung Hong,Chung-Jen Teng,Man-Hsin Hung,Yu-Wen Hu,Fan-Chen Ku,Yung-Tai Chen,Sheng-Hsuan Chien,Chiu-Mei Yeh,Tzeng-Ji Chen,Tzeon-Jye Chiou,Jyh-Pyng Gau,Cheng-Hwai Tzeng | | International Journal of Cancer. 2014; : n/a | | [Pubmed] | [DOI] | | | 5 |
Tuberculous and non-tuberculous granulomatous lymphadenitis in patients receiving imatinibmesylate (glivec) for metastatic gastrointestinal stromal tumor |
|
| Agaimy, A. and Brueckl, V. and Schmidt, D. and Krieg, S. and Ullrich, E. and Meidenbauer, N. | | Case Reports in Oncology. 2013; 6(1): 134-142 | | [Pubmed] | | | 6 |
Role of progesterone receptor expression and proliferative activity in predicting the recurrence of meningioma |
|
| Nafissa M. El-Badawy,Rola M. Farid,Liala N. Nagib,Riham A. Ibrahim | | Egyptian Journal of Pathology. 2013; 33(1): 76 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
